Authors

• Jeffrey S. Morris (ORCID: https://orcid.org/0000-0002-8520-6088)
• Hesham M. Amin (ORCID: https://orcid.org/0000-0002-7973-6699)
• Shadi Chamseddine (ORCID: https://orcid.org/0000-0001-7715-0689)
• Michael LaPelusa (ORCID: https://orcid.org/0000-0001-6078-0561)
• Rikita Hatia (ORCID: https://orcid.org/0000-0003-2591-5963)
• Ryan Sun (ORCID: https://orcid.org/0000-0003-1176-1561)
• James C. Yao (ORCID: https://orcid.org/0000-0002-1875-3962)
• Ahmed Omar Kaseb (ORCID: https://orcid.org/0000-0002-9491-0587)
• Sunyoung S. Lee (ORCID: https://orcid.org/0000-0002-5954-5991)
• Lianchun Xiao (ORCID: https://orcid.org/0000-0003-0972-2766)
• Zishuo Ian Hu
• Betül Gök Yavuz (ORCID: https://orcid.org/0000-0003-3786-1456)
• Yehia I. Mohamed (ORCID: https://orcid.org/0000-0002-5192-3804)
• Maria Diab (ORCID: https://orcid.org/0000-0002-4809-9535)
• Ahmed Nassar (ORCID: https://orcid.org/0000-0001-8047-0069)
• Amr Mohamed (ORCID: https://orcid.org/0000-0002-3310-6413)
• Dan G. Duda
• Manal M. Hassan (ORCID: https://orcid.org/0000-0002-8413-449X)

Institutions

• The University of Texas MD Anderson Cancer Center (US)
• Harvard University (US)
• Emory University (US)
• University Hospitals of Cleveland (US)
• Massachusetts General Hospital (US)
• University of Missouri (US)
• University of Pennsylvania (US)
• The University of Texas Health Science Center at Houston (US)

Publication Details

Journal

Journal of Immunotherapy and Precision Oncology

Published

2024-09-09

DOI

https://doi.org/10.36401/jipo-24-6

Citations

6

Primary Topic

Galectins and Cancer Biology

Type

article

Field-Weighted Citation Impact

1.44

Funders

• U.S. Department of Defense
• Exelixis
• National Institutes of Health
• National Cancer Institute
• DOD Peer Reviewed Cancer Research Program